Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcomafor Sarcoma MetastaticSites in Charlotte & Winston-SalemSponsor: Wake Forest University Health SciencesSex: All·Age: 18+Code: NCT07291297·Phase 2·Recruiting·Listed Dec 2025Apply to this trial
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Studyfor Metastatic Breast CancerSites in Charlotte, Matthews +71 more locationsSponsor: American Society of Clinical OncologySex: All·Age: 65+Code: NCT06377852·Phase 3·Recruiting·Listed Apr 2024Apply to this trial
Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathwayfor CancerSites in Charlotte & Winston-SalemSponsor: Wake Forest University Health SciencesSex: All·Age: 65+Code: NCT07175376·Recruiting·Listed Sep 2025Apply to this trial
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantationfor Multiple MyelomaDrug: TeclistamabSites in Charlotte, Durham +39 more locationsSponsor: European Myeloma Network B.V.Sex: All·Age: 18+Code: NCT05243797·Phase 3·Recruiting·Listed Feb 2022Apply to this trial
Digoxin Medulloblastoma Studyfor MedulloblastomaSites in Charlotte, Chapel Hill +13 more locationsSponsor: H. Lee Moffitt Cancer Center and Research InstituteSex: All·Age: 12 Months - 30Code: NCT06701812·Phase 2·Recruiting·Listed Nov 2024Apply to this trial
Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgeryfor Head and Neck CancerSites in Charlotte, Winston-Salem +1 more locationSponsor: Wake Forest University Health SciencesSex: All·Age: 18+Code: NCT06607406·Recruiting·Listed Sep 2024Apply to this trial
Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacyfor Leukemia, Not Otherwise Specified1 location in CharlotteSponsor: Wake Forest University Health SciencesSex: All·Age: 18+Code: NCT03555851·Recruiting·Listed Jun 2018Apply to this trial
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54for Lung Neoplasms1 location in CharlotteSponsor: Wake Forest University Health SciencesSex: All·Age: 40 - 54·Accepts healthy volunteersCode: NCT04577599·Recruiting·Listed Oct 2020Apply to this trial
Pre-malignant States to Hematologic Malignancies in Firefightersfor Clonal Hematopoiesis of Indeterminate Potential1 location in CharlotteSponsor: Wake Forest University Health SciencesSex: All·Age: 40 - 49·Accepts healthy volunteersCode: NCT06870760·Recruiting·Listed Mar 2025Apply to this trial
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myelomafor Multiple MyelomaSites in Charlotte, Chapel Hill +3 more locationsSponsor: UNC Lineberger Comprehensive Cancer CenterSex: All·Age: 18+Code: NCT05145400·Phase 2·Recruiting·Listed Dec 2021Apply to this trial
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissuefor Pediatric Sarcoma, RefractorySites in Charlotte, Chapel Hill +20 more locationsSponsor: Nationwide Children's HospitalSex: All·Age: 2 - 40Code: NCT05634369·Phase 1, Phase 2·Recruiting·Listed Dec 2022Apply to this trial
Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemiafor Severe Aplastic AnemiaSites in Charlotte, Chapel Hill +23 more locationsSponsor: Medical College of WisconsinSex: All·Age: 3 - 75Code: NCT06517641·Phase 2·Recruiting·Listed Jul 2024Apply to this trial
LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patientsfor SarcomaSites in Charlotte & Winston-SalemSponsor: Wake Forest University Health SciencesSex: All·Age: All agesCode: NCT06958107·Recruiting·Listed May 2025Apply to this trial
Patient Descriptors Of Cancer-Related Fatigue: A Mixed Methods Pilot Study Of Cancer Survivorsfor CancerSites in Charlotte & Winston-SalemSponsor: Wake Forest University Health SciencesSex: All·Age: 18+Code: NCT06634381·Recruiting·Listed Oct 2024Apply to this trial
Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AMLfor Leukemia, Myeloid, AcuteDrug: VenetoclaxSites in Charlotte & Winston-SalemSponsor: Wake Forest University Health SciencesSex: All·Age: 18+Code: NCT06580106·Recruiting·Listed Aug 2024Apply to this trial
Discharge Medication Use Post-Operatively in GU Cancer Patientsfor Genitourinary Cancer1 location in CharlotteSponsor: Wake Forest University Health SciencesSex: All·Age: 18+Code: NCT06795087·Recruiting·Listed Jan 2025Apply to this trial
Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patientsfor Pediatric Cancer1 location in CharlotteSponsor: Wake Forest University Health SciencesSex: All·Age: 2 - 21Code: NCT04948619·Phase 2·Recruiting·Listed Jul 2021Apply to this trial
Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinomafor Pancreas AdenocarcinomaSites in Charlotte & Winston-SalemSponsor: Wake Forest University Health SciencesSex: All·Age: 18+Code: NCT05376592·Recruiting·Listed May 2022Apply to this trial
WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer Treatmentfor Pancreatic Cancer1 location in CharlotteSponsor: Wake Forest University Health SciencesSex: All·Age: 18+Code: NCT06291324·Recruiting·Listed Mar 2024Apply to this trial